课题基金 / 基金详情

Molecular Mechanisms of Neurodegeneration

Molecular Mechanisms of Neurodegeneration
神经退行性变的分子机制
批准号:
7895055
负责人:
Alexander Gow
金额:
$38.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-16 至 2012-06-30

项目摘要

项目成果

Alexander Gow的其他基金

相似基金

相关文献

中文摘要
翻译
这项研究的长期目标是定义和描述蛋白质突变导致神经退行性疾病的分子机制,并确定改善神经细胞中未折叠的蛋白质中间体积累引起的疾病症状的药理学药物。未折叠蛋白在细胞内区室的积累是
英文摘要
The long term goals of this research are to define and characterize molecular mechanisms by which mutations in proteins cause neurodegenerative disease and to identify pharmacological agents that ameliorate disease symptoms stemming from the accumulation of unfolded protein intermediates in neural cells. The accumulation of unfolded proteins in intracellular compartments is thought to underlie pathogenesis for a number of neurodegenerative diseases, including ALS, Parkinson, Huntington and Alzheimer diseases. More recently, the unfolded protein response has also been implicated in the pathophysiology of metabolic syndrome (diabetes/obesity/insulin resistance/cardiovascular disease), which significantly increases the impact of our work because unfolded diseases may be relevant to more than 6% of Americans. Two key components of our research have been the availability of well-defined mouse models for genetic manipulation, such as gene ablation or the introduction of heterologous transgenes, and the willingness of patients with unfolded protein disease to be involved in clinical studies. In this application, we will continue our work with patients to measure several clinical metrics from MRI and correlate these with disease severity. In addition, we will generate a novel mouse model on unfolded protein disease that will allow us to extend our understanding of the pathophysiology of unfolded protein disease. Specific Aim#1: we will develop a novel in vivo mouse model in which the unfolded protein response can be followed in real time, in individual cells, in vivo. This model will allow us to identify novel gene targets of UPR-induced transcription factors. Currently, several targets have been identified from in vitro cells in culture; however, we find that the data from in vivo experiments often contradict in vitro studies. Our paradigm will enable us to characterize the temporal sequence of events that generate the pathophysiology of neurodegeneration associated with protein trafficking defects in oligodendrocytes.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
Using temporal genetic switches to synchronize the unfolded protein response in cell populations in vivo.
使用时间遗传开关来同步体内细胞群中未折叠蛋白质的反应。
DOI: 10.1016/b978-0-12-385928-0.00009-2
发表时间: 2011
期刊: Methods in enzymology
影响因子: --
作者: [Gow,Alexander]
通讯作者: Gow,Alexander
Variable expression of a novel PLP1 mutation in members of a family with Pelizaeus-Merzbacher disease.
Pelizaeus-Merzbacher 病家族成员中新型 PLP1 突变的可变表达。
DOI: 10.1177/0883073808327833
发表时间: 2009
期刊: Journal of child neurology
影响因子: 1.9
作者: [Fattal-Valevski,Aviva, DiMaio,MiriamS, Hisama,FukiM, Hobson,GraceM, Davis-Williams,Angelique, Garbern,JamesY, Mahoney,MauriceJ, Kolodny,EdwinH, Pastores,GregoryM]
通讯作者: Pastores,GregoryM
DOI: 10.1016/s1063-5823(10)65010-7
发表时间: 2010
期刊: CURRENT TOPICS IN MEMBRANES
影响因子: --
作者: [Devaux, Jerome, Fykkolodziej, Bozena, Gow, Alexander]
通讯作者: Gow, Alexander
Novel alternatively spliced endoplasmic reticulum retention signal in the cytoplasmic loop of Proteolipid Protein-1.
Proteolipid Protein-1 细胞质环中的新型选择性剪接内质网保留信号。
DOI: 10.1002/jnr.21153
发表时间: 2007
期刊: Journal of neuroscience research
影响因子: 4.2
作者: [Southwood,Cherie, Olson,Kevin, Wu,Chia-Yen, Gow,Alexander]
通讯作者: Gow,Alexander
共 8 条
    The apical junction complex in cochlear basal cells
    • 批准号:
      9896080
    • 项目类别:
    • 资助金额:
      $23.1万
    • 财政年份:
      2020
    • 负责人:
      Alexander Gow
    • 依托单位:
    Trb3-Mediated Modulation of Oligodendrocyte Stress
    • 批准号:
      8270414
    • 项目类别:
    • 资助金额:
      $38.0万
    • 财政年份:
      2011
    • 负责人:
      Alexander Gow
    • 依托单位:
    Hearing loss in claudin 11-null mice
    • 批准号:
      6776352
    • 项目类别:
    • 资助金额:
      $24.05万
    • 财政年份:
      2003
    • 负责人:
      Alexander Gow
    • 依托单位:
    Hearing loss in claudin 11-null mice
    • 批准号:
      6922923
    • 项目类别:
    • 资助金额:
      $24.05万
    • 财政年份:
      2003
    • 负责人:
      Alexander Gow
    • 依托单位:
    海外基金